OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 97 filers reported holding OLEMA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $145,165 | +175.9% | 13,416 | -11.5% | 0.00% | – |
| Q1 2023 | $52,609 | +52.1% | 15,161 | +7.4% | 0.00% | – |
| Q4 2022 | $34,594 | -66.4% | 14,120 | -62.2% | 0.00% | -100.0% |
| Q3 2022 | $103,000 | -63.2% | 37,314 | -45.7% | 0.00% | -50.0% |
| Q2 2022 | $280,000 | -30.3% | 68,735 | -27.1% | 0.00% | -33.3% |
| Q1 2022 | $402,000 | -49.6% | 94,290 | +10.7% | 0.00% | -62.5% |
| Q4 2021 | $797,000 | -30.9% | 85,198 | +103.7% | 0.01% | -46.7% |
| Q3 2021 | $1,153,000 | +1821.7% | 41,832 | +1845.7% | 0.02% | +1400.0% |
| Q2 2021 | $60,000 | – | 2,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
| Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
| BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
| Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
| Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
| Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
| Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
| Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
| Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |